CEMI: Chembio Diagnostics, Inc. - 5.9994, $73.85M, -0.00 (-0.01%)

Sector: Healthcare - Industry: Diagnostic Substances

Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care (POC) diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV and syphilis antibodies. The companys products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV 1/2 Assay Test, which detect antibodies to HIV 1 and 2 with visually interpreted results; a DPP HIV-Syphilis multiplex test for the detection of antibodies to HIV and Syphilis; and a rapid test for the detection of Hepatitis-C antibodies. Chembio Diagnostics, Inc. sells its products under STAT-PAK, SURE CHECK, or DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medic

Past CEMI reports

Earning Date	Time	Title	EPS-e	EPS-a	Close	Prev Close	Open	Day Low	Day High	Gap %	CFO %	Change %	Volume
2017-03-07	AMC		-0.15		5.7	5.85	5.75	5.27	5.81	-1.71%	-0.87%	-2.56%	80.56K
2016-11-10	BMO		-0.17		6.7	6.85	7.1	6.45	7.1	3.65%▲	-5.63%	-2.19%	64.26K
2016-08-11	BMO		-0.16		6.46	6.74	6.33	6.33	6.86	-6.08%	2.05%	-4.15%	226.63K
2016-07-25	BMO		-0.11		7.06	8.45	7.9	7.05	7.99	-6.51%	-10.63%	-16.45%	346.06K
2016-05-12	BMO		-0.09		7.47	7.275	7.37	7.27	7.49	1.31%	1.36%	2.68%	65.37K
2016-03-08	BMO		-0.09		5.54	5.69	5.7	5.25	5.7	0.18%	-2.81%	-2.64%	132.25K
2015-11-12			-0.07		5.31	5.26	5.3	5.19	5.38	0.76%▲	0.19%	0.95%	20.69K
2015-08-06					4.78	4.885	4.885	4.66	4.9		-2.15%	-2.15%	21.76K
2015-05-07			-0.11		4.58	4.73	4.7	4.57	4.7	-0.63%	-2.55%	-3.17%	3.43K
2015-03-05	BMO		-0.03		4.02	4.13		4.02	4.13			-2.66%	19.43K
2014-11-06	BMO	Chembio Diagnos	-0.03		4.26	4.27	4.25	4.1	4.4	-0.47%▲	0.24%	-0.23%	114.00K
2014-08-07	BMO	Chembio Diagnos	-0.02		3.49	3.26	3.39	3.28	3.52	3.99%	2.95%	7.06%	106.90K
2014-05-08	BMO	Chembio Diagnos	-0.02		2.87	3.13	3.02	2.83	3.02	-3.51%	-4.97%	-8.31%	121.70K
2014-03-06	BMO	Chembio Diagnos	0.04	-0.03	3.58	3.73	3.65	3.54	3.74	-2.14%	-1.92%	-4.02%	78.70K
2013-11-07	AMC	Chembio Diagnos	0.06	0.07	3.6	3.85	3.85	3.47	3.95	▲	-6.49%	-6.49%	171.60K
2013-08-08	BMO	Chembio Diagnos	-0.02	-0.03	4.2	4.45	4.25	4.12	4.32	-4.49%	-1.18%	-5.62%	108.60K
2013-05-09	BMO		0.02		4.35	4.59	4.49	4.31	4.56	-2.18%	-3.12%	-5.23%	66.01K
2013-03-07	AMC		0.05		5.65	5.4499	5.47	5.25	5.7	0.37%	3.29%	3.67%	62.53K
2012-11-13	BMO		0.04		4.12	4.11	3.87	3.61	4.15	-5.84%▲	6.46%	0.24%	61.35K
2012-08-09		Chembio Diagnos	0.05	0.04	4.92	4.98	5.14	4.65	5.14	3.21%	-4.28%	-1.20%	29.40K
2012-05-10		Chembio Diagnos	0.01		0.51	0.52	0.51	0.51	0.53	-1.92%		-1.92%	11.20K
2012-03-08	BMO	Chembio Diagnos	0.01		0.5	0.46	0.48	0.47	0.5	4.35%	4.17%	8.70%	29.40K
2011-11-03	BMO	Chembio Diagnos		0.01	0.46	0.45	0.45	0.45	0.46	▲	2.22%	2.22%	18.30K
2011-08-04	BMO	Chembio Diagnos			0.38	0.43	0.41	0.3	0.43	-4.65%	-7.32%	-11.63%	91.60K
2011-05-05	BMO	Chembio Diagnos			0.52	0.56	0.56	0.48	0.57		-7.14%	-7.14%	13.30K
2011-03-03	BMO	Chembio Diagnos		0.03	0.45	0.42	0.45	0.43	0.5	7.14%		7.14%	32.50K
2010-11-04	BMO	Chembio Diagnos			0.33	0.24	0.25	0.25	0.33	4.17%▲	32.00%	37.50%	325.60K
2010-07-29	BMO	Chembio Diagnos	-0.01		0.24	0.26	0.26	0.24	0.26		-7.69%	-7.69%	28.10K
2010-05-06	BMO	Chembio Diagnos			0.2	0.21	0.2	0.2	0.23	-4.76%		-4.76%	26.90K
2010-03-05	BMO	Chembio Diagnos			0.27	0.27	0.3	0.25	0.31	11.11%	-10.00%		101.30K
2009-11-04	AMC	Chembio Diagnos			0.37	0.35	0.36	0.31	0.39	2.86%▲	2.78%	5.71%	48.70K
2009-08-06	AMC	Chembio Diagnos			0.19	0.13	0.15	0.14	0.19	15.38%	26.67%	46.15%	80.50K